Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Chronic obstructive pulmonary disease

Recruiting

Investigational

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Investigational

Hungary

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Squamous cell carcinoma of lung+6

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:BNT327

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drugNo placebo

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Budesonide

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Investigational

Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:LY3537031

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Investigational

Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:LUNSEKIMIG

Contact Research Centre

Asthma

Recruiting

Registered drugNo placebo

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Placebo

Contact Research Centre

Asthma

Recruiting

Investigational

Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood

Investigational

Hungary

Participants:18–64 years · 65+ years

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drug

Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Tezepelumab

Contact Research Centre

Asthma

Not yet recruiting

Registered drug

Study of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Salbutamol Sulfate

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Tanimilast

Contact Research Centre

Find therapies in clinical trials near you

26 trials match your criteria

Chronic obstructive pulmonary disease

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Non-small cell lung cancer+1

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Squamous cell carcinoma of lung+6

Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

Chronic obstructive pulmonary disease

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Chronic obstructive pulmonary disease

Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic obstructive pulmonary disease

Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

Asthma

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Asthma

Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood

Chronic obstructive pulmonary disease

Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Asthma

Study of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy

Chronic obstructive pulmonary disease

Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

Chronic obstructive pulmonary disease

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.